International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

A Global Collaboration to Harmonize Guidelines for Clinical Management of Ritonavir-Boosted Nirmatrelvir DDIs | Alice K. Pau

Slideset

HIV

Viral Hepatitis and Liver Disease

Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral Therapy | Mike Emerson

Slideset

HIV

Viral Hepatitis and Liver Disease

New(er) Antiretrovirals in Pregnancy and Breastfeeding | Catriona Waitt

Slideset

HIV

Viral Hepatitis and Liver Disease

Tissue-Specific Pharmacology Knowledge and Knowledge Gaps | Charles Flexner

Slideset

HIV

Viral Hepatitis and Liver Disease

Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios | Tim Cressey

Slideset

HIV

Viral Hepatitis and Liver Disease

Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell

Slideset

HIV

Viral Hepatitis and Liver Disease

Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell

Slideset

HIV

Viral Hepatitis and Liver Disease

Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia Marzolini,

Slideset

HIV

Viral Hepatitis and Liver Disease

Opening Lecture: News in Antiviral Pharmacology: A Year in Review | Andrea Calcagno

Slideset

HIV

Viral Hepatitis and Liver Disease

Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia Marzolini

Slideset

HIV

Viral Hepatitis and Liver Disease

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

A Global Collaboration to Harmonize Guidelines for Clinical Management of Ritonavir-Boosted Nirmatrelvir DDIs | Alice K. Pau

The Use of AI in Clinical Pharmacology | Lauren Walker

Is TDM Still Needed / Useful ? | Nancy Sheehan

Case Presentation - Complex DDI case | Dario Cattaneo

A Year of CAB/RPV Use, What Have We Learned in the Real World | Emma Rubenstein

Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral Therapy | Mike Emerson

New(er) Antiretrovirals in Pregnancy and Breastfeeding | Catriona Waitt

Tissue-Specific Pharmacology Knowledge and Knowledge Gaps | Charles Flexner

Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios | Tim Cressey

Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell

Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell

Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia Marzolini,

Opening Lecture: News in Antiviral Pharmacology: A Year in Review | Andrea Calcagno

Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia Marzolini

A (PK) Study in Scarlet: Investigating Target Concentrations | Paolo Denti